GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Pfizer Ltd

Pfizer Ltd: Two senior management departures effective July 2026 and March 2026

MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 31 Mar 2026, 06:39 PM IST  ·  BSE ID: 5355e74f-8bf0-426c-a28c-7386e5ab9919
View Original BSE Filing (PDF)
💡
In Simple Terms
Two senior executives left Pfizer: one resigned to pursue outside opportunities; another moved to a different Pfizer group company.
🤖 AI Summary
  • Mr. Deepak Rakheja resigned as Strategic Partnerships and Channel Development Lead, effective July 8, 2026
  • Mr. Anil Pattanshetty transitioned to another Pfizer Group Company, effective March 31, 2026
  • Both classified as Senior Management Personnel changes under SEBI Regulation 30
  • Rakheja's resignation letter submitted per SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
🔢 Key Numbers — exact figures from BSE filing, not rounded
Mr. Deepak Rakheja resignation effective date
July 8, 2026 (close of business)
Mr. Anil Pattanshetty transition effective date
April 1, 2026
🏢 How This Affects the Company
⚙️
Operational Impact
Loss of Strategic Partnerships, Channel Development and International Neighbouring Markets Lead, with a 3.5-month transition period until July 8, 2026. Senior Director Business Operations transferred internally effective March 31, 2026.
⚠️
Risk Impact
Departure of two senior management members creates continuity risk in strategic partnerships and business operations functions, with potential disruption to ongoing initiatives and relationships.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor Q2 and Q3 FY26 updates for successor announcements and business continuity measures.
👤
Who Is Affected
All shareholders equally affected. Changes impact management continuity in strategic partnerships and operations functions across all shareholder classes.
🔍
Management Signal
Internal talent movement (Pattanshetty) suggests group-wide resource redeployment; external departure (Rakheja) indicates loss of specialized expertise to market.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Successor announcement for Strategic Partnerships Lead role — expected within 2-3 months of Rakheja departure
Q2 FY26 results disclosure for management commentary on channel strategy continuity
Any material order impact disclosure related to international neighbouring markets in next quarterly filing
MEDIUM RISK Loss of Strategic Partnerships Lead creates execution risk in international channel development and neighbouring markets until replacement filled.
💡 Investor Takeaway
Pfizer disclosed two senior management departures: Strategic Partnerships Lead resigns July 8, 2026 for external opportunities; Business Operations Senior Director transfers to another Pfizer Group Company effective March 31, 2026. No replacement announcements or successor plan disclosed in filing.
⚖️ Strengths & Concerns

⚠️ Concerns

  • Loss of Strategic Partnerships Lead creates immediate continuity gap in international neighbouring markets function until July replacement
  • Two senior management departures within 4-month window signals potential organizational instability or talent retention challenges
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.